Research ArticleClinical Studies
Open Access
Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan
DAISUKE SANO, MOTOHIKO TOKUHISA, HIDEAKI TAKAHASHI, TAKASHI HATANO, GOSHI NISHIMURA, YASUSHI ICHIKAWA and NOBUHIKO ORIDATE
Anticancer Research September 2022, 42 (9) 4477-4484; DOI: https://doi.org/10.21873/anticanres.15948